Glycerine Enfants Sopreli

Glycerine Enfants Sopreli is an over‑the‑counter glycerol (glycerine) suppository marketed in the European Union. It contains glycerol as the active ingredient, formulated as a rectal suppository to act as an osmotic laxative. The product is intended for short‑term relief of constipation in children, using the rectal route to draw water into the intestinal lumen and soften stool. It is available without prescription for occasional use.

Glycerine Enfants Sopreli is indicated for the temporary relief of constipation in pediatric patients.

- Softens stool by increasing water content in the colon. - Stimulates bowel movements through osmotic action. - Can be used when oral laxatives are not tolerated or ineffective. - Suitable for children who require a rectal route for faster onset. - May be employed as part of a bowel‑cleansing regimen prior to minor medical procedures.

The most frequently reported effects of glycerol suppositories are related to local irritation and changes in bowel habits.

Common: - Mild rectal burning or stinging sensation. - Slight cramping or abdominal discomfort. - Loose stools or mild diarrhea. - Temporary increase in gas or flatulence.

Serious: - Severe rectal pain or bleeding. - Persistent diarrhea leading to dehydration. - Signs of allergic reaction such as rash, itching, or swelling. - Unexpected abdominal pain that does not resolve.

When using Glycerine Enfants Sopreli, certain precautions should be observed to ensure safe and effective use.

- Do not use for longer than a few days without medical advice. - Avoid use in children with known hypersensitivity to glycerol or any excipients. - Consult a healthcare professional before use in infants younger than 2 years. - Ensure proper insertion technique to minimize mucosal injury. - Monitor for signs of dehydration or electrolyte imbalance, especially with repeated doses. - Keep the product out of reach of children to prevent accidental ingestion.

Glycerol suppositories have a low potential for systemic drug interactions, but certain substances may affect their safety or efficacy.

Avoid: - Concurrent use of strong stimulant laxatives, which may increase the risk of electrolyte disturbances. - Use with rectal irritants such as enemas containing harsh chemicals. - Use with anticoagulant suppositories, as local irritation could increase bleeding risk.

Use with caution: - Combination with oral osmotic laxatives (e.g., polyethylene glycol) may lead to excessive fluid loss. - Administration together with medications that cause diarrhea, such as certain antibiotics, should be monitored. - Use with antidiarrheal agents (e.g., loperamide) may reduce the intended laxative effect. - Co‑administration with drugs that require consistent intestinal absorption may be affected by altered transit time.